Edition:
United Kingdom

BioLine RX Ltd (BLRX.OQ)

BLRX.OQ on NASDAQ Stock Exchange Capital Market

0.68USD
2:35pm GMT
Change (% chg)

$0.01 (+1.80%)
Prev Close
$0.67
Open
$0.67
Day's High
$0.68
Day's Low
$0.67
Volume
2,521
Avg. Vol
142,301
52-wk High
$1.83
52-wk Low
$0.65

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 4 0.04 0.15 0.00 0.00
Year Ending Dec-18 4 0.04 0.15 0.00 2.55
Year Ending Dec-19 4 16.20 63.60 0.00 15.77
Earnings (per share)
Quarter Ending Dec-18 4 -0.09 -0.05 -0.19 -0.06
Quarter Ending Mar-19 1 -0.05 -0.05 -0.05 -0.06
Year Ending Dec-18 4 -0.25 -0.21 -0.35 -0.02
Year Ending Dec-19 4 -0.14 0.14 -0.26 -0.02
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.49 33.64
P/E High - Last 5 Yrs. -- 308.80 45.61
P/E Low - Last 5 Yrs. -- 85.15 23.70
Beta -- 0.93 0.88
Price to Sales (TTM) -- 121.71 5.95
Price to Book (MRQ) -- 14.77 4.89
Price to Tangible Book (MRQ) -- 13.90 6.50
Price to Cash Flow (TTM) -- 66.81 22.90
% Owned Institutions -- 13.77 2.15

Dividends

  Company industry sector
Dividend Yield -- 0.41 1.51
Dividend Yield - 5 Year Avg -- 0.31 1.52
Dividend 5 Year Growth Rate -- 2.84 5.41
Payout Ratio(TTM) -- 25.52 43.93

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 387.07 8.08
Sales (TTM) vs TTM 1 Yr. Ago -- 97.70 5.80
Sales - 5 Yr. Growth Rate -- 29.11 9.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 27.93 23.27
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 33.15 10.88
Capital Spending - 5 Yr. Growth Rate -- 36.76 14.85

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.02 2.27
Current Ratio (MRQ) -- 5.29 3.07
LT Debt to Equity (MRQ) -- 36.70 13.15
Total Debt to Equity (MRQ) -- 38.52 17.74
Interest Coverage (TTM) -- -90.95 37.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.86
Gross Margin - 5 Yr. Avg. -- 48.29 52.38
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -554.66 10.90
Operating Margin (TTM) -- -797.48 3.24
Operating Margin - 5 Yr. Avg. -- -575.64 6.22
Pre-Tax Margin (TTM) -- -760.60 4.31
Pre-Tax Margin - 5 Yr. Avg. -- -581.03 6.66
Net Profit Margin (TTM) -- -761.46 0.58
Net Profit Margin - 5 Yr. Avg. -- -583.67 2.90
Effective Tax Rate (TTM) -- 25.03 23.26
Effective Tax Rate - 5 Yr. Avg. -- 19.86 24.21

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,792,354 803,310,882
Net Income/Employee (TTM) -- 1,402,733 94,478,474
Receivable Turnover (TTM) -- 19.90 5.78
Inventory Turnover (TTM) -- 2.68 3.71
Asset Turnover (TTM) -- 0.42 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.66 10.86
Return on Assets - 5 Yr. Avg. -- 2.77 11.96
Return on Investment (TTM) -- -0.29 14.22
Return on Investment - 5 Yr. Avg. -- 1.51 15.54
Return on Equity (TTM) -- 0.40 15.99
Return on Equity - 5 Yr. Avg. -- 1.96 16.82
Note: Units in Millions of US Dollars

Performance for BioLine RX Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.